Page last updated: 2024-08-24

colestipol and Coronary Disease

colestipol has been researched along with Coronary Disease in 45 studies

Research

Studies (45)

TimeframeStudies, this research(%)All Research%
pre-199025 (55.56)18.7374
1990's15 (33.33)18.2507
2000's5 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lucas, BD1
Stamler, J2
Glueck, CJ1
Farinaro, E; Mancini, M; Montefusco, S; Postiglione, A1
Kuo, PT1
Buchwald, H; Fitch, L; Moore, RB1
Greten, H; Klose, G1
Kostis, JB; Kuo, PT; Moreyra, AE1
Esente, P; Gensini, G; Nash, DT1
Untereker, WJ1
Kolb, S; Sailer, D1
Hayes, JA; Kostis, JB; Kuo, PT; Moreyra, AE1
Azen, SP; LaBree, L; Lapuerta, P1
Ginsberg, HN1
Albers, JJ; Brown, BG; Hillger, L; Poulin, D; Zhao, XQ1
Albers, JJ; Brown, BG; Dowdy, A; Fisher, LD; Hillger, LA; Sniderman, AD; Stewart, BF; Zhao, XQ1
Hathaway, SC; Paat, JJ; Paterson, RW; Steele, GH; Wong, JG1
Albers, JJ; Bisson, B; Brown, BG; Fisher, L; Hillger, L; Sacco, D; Zhao, XQ1
Coates, PM; Cortner, JA; Jarvik, GP; Liacouras, CA1
Hiatt, J; Schectman, G1
Bambauer, R; Müller, UA; Schiel, R1
Avery, BR1
Albers, JJ; Brown, BG; Brunzell, JD; Davis, JW; Maher, VM; Poulin, D; Rocha, A; Zambon, A1
Oster, G; Thompson, D1
Faulkner, MA; Hilleman, DE; Lucas, BD; Wadibia, EC1
Brown, BG; Brunzell, JD; Deeb, SS; Hokanson, JE; Zambon, A1
Susekov, AV1
Goldbourt, U; Graff, E; Koren-Morag, N; Tanne, D1
Hayase, K; Kostis, JB; Kuo, PT; Moreyra, AE1
Grundy, SM1
Stone, NJ1
Dorr, AE; Gundersen, K; Martin, WB; Schneider, JC; Spencer, TW1
Blankenhorn, DH; Sanmarco, ME1
Baggio, G; Baiocchi, MR; Balestrieri, P; Briani, G; Crepaldi, G; Fellin, R1
Schon, P1
Albers, JJ; Bisson, BD; Brown, G; Dodge, HT; Fisher, LD; Fitzpatrick, VF; Kaplan, C; Lin, JT; Schaefer, SM; Zhao, XQ1
Potts, JF; Setness, PA1
Anding, RH; Lueg, MC1
Eisenberg, JM; Kinosian, BP1
Naito, HK1
Gotto, AM; Jones, PH; Scott, LW1
Kostis, JB; Kuo, PT; Moreyra, AE; Wilson, AC1
Hüppe, R; Kohlmeier, M; Schlierf, G; Schmidt-Gayk, H; Vogel, G; Vuilleumier, JP1

Reviews

10 review(s) available for colestipol and Coronary Disease

ArticleYear
Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens.
    Clinical cardiology, 1995, Volume: 18, Issue:6

    Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Coronary Disease; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Niacin

1995
Impact of intensive lipid modulation on angiographically defined coronary disease: clinical implications.
    Southern medical journal, 1994, Volume: 87, Issue:2

    Topics: Angiography; Clinical Trials as Topic; Colestipol; Coronary Disease; Humans; Hypercholesterolemia; Lipids; Lovastatin; Niacin; Random Allocation

1994
Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
    The Journal of pediatrics, 1993, Volume: 123, Issue:2

    Topics: Adolescent; Apolipoproteins B; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Genetic Linkage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Lipoproteins, VLDL; Liver; Male; Multigene Family; Niacin; Phenotype; Polymorphism, Genetic; Triglycerides

1993
Use of niacin, statins, and resins in patients with combined hyperlipidemia.
    The American journal of cardiology, 1998, Feb-26, Volume: 81, Issue:4A

    Topics: Anticholesteremic Agents; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Cohort Studies; Colestipol; Coronary Disease; Drug Therapy, Combination; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lovastatin; Niacin; Risk Factors; Triglycerides

1998
Cost-effectiveness of drug therapy for hypercholesterolaemia: a review of the literature.
    PharmacoEconomics, 1992, Volume: 2, Issue:1

    Topics: Age Factors; Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Lovastatin; Risk Factors; Sex Factors; Treatment Outcome

1992
[Substantiation of increasing doses of statins in clinical practice].
    Terapevticheskii arkhiv, 2001, Volume: 73, Issue:4

    Topics: Adult; Aged; Angiography; Animals; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Clinical Trials as Topic; Colestipol; Coronary Disease; Dogs; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Lovastatin; Male; Meta-Analysis as Topic; Middle Aged; Primates; Prospective Studies; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Time Factors

2001
Treatment of hypercholesterolemia.
    The American journal of clinical nutrition, 1977, Volume: 30, Issue:6

    Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Diet, Reducing; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Ileum; Intestinal Absorption; Nicotinic Acids; Triglycerides

1977
Reducing cardiac deaths with hypolipidemic drugs.
    Postgraduate medicine, 1987, Nov-01, Volume: 82, Issue:6

    Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol

1987
The diagnosis and management of hyperlipidemia.
    Disease-a-month : DM, 1986, Volume: 32, Issue:5

    Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides

1986
Review of primary prevention trials of coronary heart disease.
    Acta medica Scandinavica. Supplementum, 1985, Volume: 701

    Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dietary Fats; Electrocardiography; Humans; Male; Middle Aged; Physical Exertion; Risk; Smoking Prevention; Stress, Psychological

1985

Trials

15 trial(s) available for colestipol and Coronary Disease

ArticleYear
Pharmacological trials: primary and secondary prevention of coronary heart disease.
    Preventive medicine, 1983, Volume: 12, Issue:1

    Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone

1983
Overview of randomized clinical trials of lipid intervention for atherosclerotic cardiovascular disease.
    Controlled clinical trials, 1982, Volume: 3, Issue:3

    Topics: Arteriosclerosis; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Fatty Acids, Unsaturated; Glycine max; Humans; Hypolipidemic Agents; Lipids; Nicotinic Acids; Oils; Random Allocation; Risk; Zea mays

1982
Types of change in coronary stenosis severity and their relative importance in overall progression and regression of coronary disease. Observations from the FATS Trial. Familial Atherosclerosis Treatment Study.
    Annals of the New York Academy of Sciences, 1995, Jan-17, Volume: 748

    Topics: Adult; Colestipol; Coronary Disease; Diet, Fat-Restricted; Humans; Lovastatin; Male; Middle Aged; Niacin

1995
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.
    Journal of the American College of Cardiology, 1994, Mar-15, Volume: 23, Issue:4

    Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Apolipoproteins B; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Niacin; Treatment Outcome

1994
Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B.
    Circulation, 1993, Volume: 88, Issue:6

    Topics: Adult; Apolipoproteins B; Colestipol; Coronary Disease; Coronary Vessels; Double-Blind Method; Exercise Test; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Niacin; Radiography

1993
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
    The International journal of artificial organs, 1995, Volume: 18, Issue:12

    Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Longitudinal Studies; Lovastatin; Male; Middle Aged; Niacin; Pravastatin; Quality of Life

1995
Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial.
    Pharmacotherapy, 2000, Volume: 20, Issue:4

    Topics: Aged; Cholesterol; Colestipol; Coronary Disease; Counseling; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Myocardial Revascularization; Patient Compliance; Pharmacists; Time Factors; Treatment Outcome; Triglycerides

2000
Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment.
    Circulation, 2001, Feb-13, Volume: 103, Issue:6

    Topics: Analysis of Variance; Cholesterol, HDL; Colestipol; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Genotype; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Lovastatin; Male; Middle Aged; Niacin; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Promoter Regions, Genetic; Regression Analysis

2001
Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry.
    Archives of internal medicine, 2002, May-13, Volume: 162, Issue:9

    Topics: Adult; Aged; Bezafibrate; Brain Ischemia; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Disease; Follow-Up Studies; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Lovastatin; Middle Aged; Multivariate Analysis; Odds Ratio; Registries; Risk Factors; Survival Analysis; Time Factors

2002
Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
    Circulation, 1979, Volume: 59, Issue:2

    Topics: Adult; Aged; Angina Pectoris; Arteriosclerosis; Cholesterol; Colestipol; Coronary Disease; Dietary Carbohydrates; Dietary Fats; Drug Evaluation; Female; Follow-Up Studies; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Placebos; Polyamines; Radiography; Triglycerides; Xanthomatosis

1979
Cholesterol, colestipol and coronary heart disease.
    Journal of chronic diseases, 1978, Volume: 31, Issue:1

    Topics: Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Disease; Evaluation Studies as Topic; Female; Humans; Male; Polyamines; Research Design

1978
Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality.
    Journal of chronic diseases, 1978, Volume: 31, Issue:1

    Topics: Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Disease; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Placebos; Polyamines

1978
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
    The New England journal of medicine, 1990, Nov-08, Volume: 323, Issue:19

    Topics: Adult; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Disease; Diet; Double-Blind Method; Drug Therapy, Combination; Humans; Lovastatin; Male; Middle Aged; Multivariate Analysis; Niacin

1990
Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
    The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16

    Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Combined Modality Therapy; Coronary Disease; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Phenols; Polyamines; Probucol; Triglycerides

1986
Review of primary prevention trials of coronary heart disease.
    Acta medica Scandinavica. Supplementum, 1985, Volume: 701

    Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dietary Fats; Electrocardiography; Humans; Male; Middle Aged; Physical Exertion; Risk; Smoking Prevention; Stress, Psychological

1985

Other Studies

21 other study(ies) available for colestipol and Coronary Disease

ArticleYear
Lipid-lowering therapy after coronary artery bypass grafting: time for more aggressive intervention.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, Nov-01, Volume: 59, Issue:21

    Topics: Colestipol; Coronary Artery Bypass; Coronary Disease; Humans; Hypolipidemic Agents; Lovastatin; Patient Compliance; Randomized Controlled Trials as Topic; Treatment Outcome

2002
Therapy of familial and acquired hyperlipoproteinemia in children and adolescents.
    Preventive medicine, 1983, Volume: 12, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Infant; Infant Food; Lipoproteins, LDL; Male; Patient Compliance; Triglycerides

1983
Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
    Preventive medicine, 1983, Volume: 12, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Plasma Exchange; Polyamines

1983
Treating hyperlipidemia to provide salutary effect on coronary artery disease.
    Chest, 1984, Volume: 85, Issue:4

    Topics: Arteriosclerosis; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Lipoproteins, LDL

1984
[Lipid lowering treatment and regression of arteriosclerosis (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1980, Mar-28, Volume: 122, Issue:13

    Topics: Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Clofibrate; Colestipol; Coronary Disease; Haplorhini; Humans; Nicotinic Acids

1980
Protection of myocardium by the compensatory mechanism of coronary collaterals after total occlusion of major coronary arteries shown in patients with familial hypercholesterolemia.
    American heart journal, 1982, Volume: 104, Issue:1

    Topics: Adult; Arterial Occlusive Diseases; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Colestipol; Coronary Circulation; Coronary Disease; Electrocardiography; Female; Heart; Heart Function Tests; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Niacin; Nicotinic Acids; Radiography; Radionuclide Imaging

1982
Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography.
    International journal of cardiology, 1982, Volume: 2, Issue:1

    Topics: Cholesterol; Colestipol; Coronary Angiography; Coronary Disease; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Polyamines; Risk; Triglycerides

1982
Treatment of hypercholesterolemia. Can it retard atherogenesis?
    International journal of cardiology, 1982, Volume: 2, Issue:1

    Topics: Cholesterol; Colestipol; Coronary Angiography; Coronary Disease; Humans; Hypercholesterolemia; Polyamines; Risk

1982
[Treatment of coronary heart disease with diet and lipid-reducing agents].
    Fortschritte der Medizin, 1982, Nov-18, Volume: 100, Issue:43

    Topics: Adolescent; Adult; Child; Cholestyramine Resin; Clofibrate; Clofibric Acid; Colestipol; Coronary Disease; Dextrothyroxine; Humans; Hypolipidemic Agents; Nicotinic Acids; Risk

1982
Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment.
    Chest, 1981, Volume: 79, Issue:3

    Topics: Adult; Angiography; Cholesterol; Cholesterol, Dietary; Colestipol; Coronary Angiography; Coronary Disease; Coronary Vessels; Dietary Carbohydrates; Dietary Fats; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Nicotinic Acids; Polyamines; Triglycerides

1981
Use of neural networks in predicting the risk of coronary artery disease.
    Computers and biomedical research, an international journal, 1995, Volume: 28, Issue:1

    Topics: Adult; Cholesterol; Colestipol; Coronary Artery Disease; Coronary Disease; Diet, Fat-Restricted; Follow-Up Studies; Forecasting; Humans; Lipids; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Neural Networks, Computer; Niacin; Placebos; Randomized Controlled Trials as Topic; Regression Analysis; Reproducibility of Results; Risk Factors

1995
Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals.
    The American journal of medicine, 1996, Volume: 100, Issue:2

    Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Colestipol; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Niacin; Peripheral Vascular Diseases; Retrospective Studies; Treatment Outcome; Triglycerides

1996
Treatment of the patient with primary familial heterozygous hypercholesterolemia.
    The Journal of cardiovascular nursing, 1995, Volume: 9, Issue:2

    Topics: Aged; Colestipol; Coronary Disease; Diet, Fat-Restricted; Drug Therapy, Combination; Exercise; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Niacin; Patient Compliance; Weight Loss

1995
Angiography for study of lipid-lowering therapy.
    Circulation, 1979, Volume: 59, Issue:2

    Topics: Colestipol; Coronary Angiography; Coronary Disease; Drug Evaluation; Humans; Hyperlipidemias; Patient Dropouts; Polyamines; Risk; Technology, Radiologic

1979
[Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
    Giornale italiano di cardiologia, 1975, Volume: 5, Issue:3

    Topics: Adult; Angina Pectoris; Cholesterol; Colestipol; Coronary Disease; Drug Evaluation; Female; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Polyamines; Triglycerides; Xanthomatosis

1975
Bile acid sequestrants and cholesterol.
    The New Zealand medical journal, 1990, Apr-11, Volume: 103, Issue:887

    Topics: Colestipol; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Polyamines

1990
Elevated cholesterol levels. How to individualize treatment.
    Postgraduate medicine, 1990, Sep-01, Volume: 88, Issue:3

    Topics: Adult; Behavior Therapy; Cholesterol, Dietary; Colestipol; Coronary Disease; Exercise; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Risk Factors; Smoking; Wine

1990
Hypercholesterolemia: new values, new strategies.
    Hospital practice (Office ed.), 1986, Jan-30, Volume: 21, Issue:1A

    Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin

1986
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
    JAMA, 1988, Apr-15, Volume: 259, Issue:15

    Topics: Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Edible Grain; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Office Visits; Polyamines; Smoking

1988
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.
    Archives of internal medicine, 1988, Volume: 148, Issue:1

    Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Male; Middle Aged; Niacin; Patient Compliance; Pentanoic Acids; Probucol; Risk Factors

1988
[Long-term therapy of familial hypercholesterolemia in young patients with colestipol: availability of minerals and vitamins].
    Klinische Wochenschrift, 1985, Sep-02, Volume: 63, Issue:17

    Topics: Adolescent; Adult; Blood Glucose; Calcium; Child; Child, Preschool; Chlorides; Colestipol; Coronary Disease; Female; Humans; Hyperlipoproteinemia Type II; Iron; Lipids; Long-Term Care; Male; Minerals; Parathyroid Hormone; Phosphates; Polyamines; Potassium; Sodium; Vitamins

1985
chemdatabank.com